Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.705
-0.003 (-0.42%)
At close: Feb 21, 2025, 4:00 PM
0.680
-0.025 (-3.55%)
After-hours: Feb 21, 2025, 7:58 PM EST
Co-Diagnostics Market Cap
Co-Diagnostics has a market cap or net worth of $22.51 million as of February 21, 2025. Its market cap has decreased by -38.66% in one year.
Market Cap
22.51M
Enterprise Value
-12.78M
1-Year Change
-38.66%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since July 12, 2017, Co-Diagnostics's market cap has decreased from $69.28M to $22.51M, a decrease of -67.51%. That is a compound annual growth rate of -13.72%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |